论文部分内容阅读
目的:观察四逆散合左金丸联合雷贝拉唑治疗胃食管反流病临床效果。方法:选取2015年3月-2016年8月我院收治的104例胃食管返流病患者作为观察目标,按照不同治疗方法分为对照组(n=52)和治疗组(n=52),对照组予以雷贝拉唑加以治疗,治疗组在予以四逆散合左金丸联合雷贝拉唑加以治疗,比较两组治疗效果和治疗前后症状总积分。结果:两组治疗前症状总积分统计比较,组间无差异(P>0.05),治疗后症状总积分比较,治疗组明显低于对照组(P<0.05);两组治疗总有效率比较,治疗组明显高于对照组,组间显著差异存在统计学意义(P<0.05)。结论:四逆散合左金丸联合雷贝拉唑有利于显著改善胃食管反流病患者的临床症状,提高整体治疗效果,值得临床选择和深度推广使用。
Objective: To observe the clinical efficacy of Sini San Zuo Jin Wan combined with Rabeprazole in the treatment of gastroesophageal reflux disease. Methods: A total of 104 patients with gastroesophageal reflux disease admitted to our hospital from March 2015 to August 2016 were selected as the observation target and divided into control group (n = 52) and treatment group (n = 52) according to different treatment methods. The rabbits in the control group were treated with rabeprazole. The patients in the treatment group were treated with Siniosan Zuojinwan combined with rabeprazole. The treatment effect and the total score of symptoms before and after treatment were compared between the two groups. Results: There was no significant difference between the two groups before treatment (P> 0.05). After treatment, the total symptom score was significantly lower in the treatment group than in the control group (P <0.05) The treatment group was significantly higher than the control group, there was significant difference between the two groups (P <0.05). Conclusion: Sini San Zuo Jin Wan combined with rabeprazole is beneficial to significantly improve the clinical symptoms of patients with gastroesophageal reflux disease and improve the overall treatment effect, which is worthy of clinical choice and in-depth promotion and use.